+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
ID06909773

A Multi-center Study of COPD Prevalence and Cardiopulmonary Co-management in Patients with Coronary Heart Disease, Atrial Fibrillation, and Chronic Heart Failure

Led by AstraZeneca · Updated on 2026-09-01

3000

Participants Needed

85

Research Sites

9 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the prevalence of chronic obstructive pulmonary disease COPD among participants aged 40 years or older who have one of three types of cardiovascular diseases coronary heart disease, atrial fibrillation, or chronic heart failure. This multi-center, prospective, interventional study aims to understand how cardiopulmonary co-management affects the short-term health outcomes of participants with both cardiovascular disease and COPD. Approximately 3,000 participants will be enrolled, with about 1,000 in each disease cohort. The study intervention includes guideline education and implementation at both the investigator and patient levels. Investigators receive education on COPD and cardiovascular disease about four weeks before enrolling participants. After enrollment, cardiologists and pulmonologists provide disease education every four weeks, along with collaborative treatment management for participants with both conditions. Participants are followed up every four weeks throughout the study. During the study, participants will undergo spirometry testing, complete questionnaires, and have various health measures recorded, including hospitalization rates and scores related to heart and lung function. Researchers will also monitor lung function tests, blood markers, and medication use at baseline and at weeks 4, 8, and 12. The primary outcome is the number and percentage of participants with COPD across the cardiovascular disease cohorts. The study includes short-term follow-up over 12 weeks to observe treatment and health changes.

CONDITIONS

Brief Title

The Prevalence of COPD in Patients With Cardiovascular Disease and the Benefit of Cardiopulmonary Co-management

Research Team

A

AstraZeneca Clinical Study Information Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here